Summary
24 / 100 · Bulios Score
What speaks for it
- It bought back its own shares for $47.0M in the last fiscal year, 3.9% of its market value.
What to watch
- Revenue fell by 15% a year over the last 3 years.
- The company made a loss over the last 12 months.
- The share price is above the Bulios Fair Price.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 16% a year over 5 years. Over the last 3 years it fell by 15% a year. For the next fiscal year analysts expect revenue to fall by 6.1%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $72.9M.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 9
- Hold 3
- Sell 1
Today's price within the analysts' price targets
The average target of $2.87 is 88% above today's price. 69% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Service 61%
- Product 26%
- Transfer of Intellectual Property and Other 13%
By region
- UNITED STATES 72%
- CHILE 10%
- IRELAND 8.5%
- SPAIN 4.4%
- MEXICO 4.2%
- Other 0.8%
Service brings in 61% of revenue. Transfer of Intellectual Property and Other grew fastest, by 33% a year.
Segments in detail